PETS vs RXMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PETS is a Buy and RXMD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PETS’s FA Score shows that 1 FA rating(s) are green whileRXMD’s FA Score has 1 green FA rating(s).
- PETS’s FA Score: 1 green, 4 red.
- RXMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PETS’s TA Score shows that 4 TA indicator(s) are bullish.
- PETS’s TA Score: 4 bullish, 4 bearish.
Price Growth
PETS (@Drugstore Chains) experienced а +39.76% price change this week, while RXMD (@Drugstore Chains) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +1.03%. For the same industry, the average monthly price growth was +3.68%, and the average quarterly price growth was +3.61%.
Reported Earning Dates
PETS is expected to report earnings on Jan 28, 2025.
RXMD is expected to report earnings on Aug 15, 2023.
Industries' Descriptions
@Drugstore Chains (+1.03% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
| PETS | RXMD | PETS / RXMD | |
| Capitalization | 99.2M | 19.7M | 504% |
| EBITDA | -5.12M | -8.77M | 58% |
| Gain YTD | -24.206 | -32.803 | 74% |
| P/E Ratio | 1465.00 | 80.00 | 1,831% |
| Revenue | 271M | 10.1M | 2,683% |
| Total Cash | 53.5M | 2.23M | 2,402% |
| Total Debt | 1.84M | 3.01M | 61% |
PETS | RXMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 36 Fair valued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 97 | |
PRICE GROWTH RATING 1..100 | 48 | 56 | |
P/E GROWTH RATING 1..100 | 1 | 18 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PETS's Valuation (36) in the Drugstore Chains industry is somewhat better than the same rating for RXMD (78) in the null industry. This means that PETS’s stock grew somewhat faster than RXMD’s over the last 12 months.
PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as RXMD (100) in the null industry. This means that PETS’s stock grew similarly to RXMD’s over the last 12 months.
PETS's SMR Rating (89) in the Drugstore Chains industry is in the same range as RXMD (97) in the null industry. This means that PETS’s stock grew similarly to RXMD’s over the last 12 months.
PETS's Price Growth Rating (48) in the Drugstore Chains industry is in the same range as RXMD (56) in the null industry. This means that PETS’s stock grew similarly to RXMD’s over the last 12 months.
PETS's P/E Growth Rating (1) in the Drugstore Chains industry is in the same range as RXMD (18) in the null industry. This means that PETS’s stock grew similarly to RXMD’s over the last 12 months.
| PETS | |
|---|---|
| RSI ODDS (%) | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 71% |
| Advances ODDS (%) | 4 days ago 70% |
| Declines ODDS (%) | 10 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 71% |
PETS and
Correlation & Price change
A.I.dvisor tells us that PETS and WBA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PETS and WBA's prices will move in lockstep.
| Ticker / NAME | Correlation To PETS | 1D Price Change % | ||
|---|---|---|---|---|
| PETS | 100% | +35.78% | ||
| WBA - PETS | 25% Poorly correlated | +0.43% | ||
| LFMD - PETS | 22% Poorly correlated | +1.38% | ||
| YI - PETS | 19% Poorly correlated | +8.42% | ||
| HITI - PETS | 12% Poorly correlated | +2.26% | ||
| RXMD - PETS | 10% Poorly correlated | N/A | ||
More | ||||
RXMD and
Correlation & Price change
A.I.dvisor tells us that RXMD and PETS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RXMD and PETS's prices will move in lockstep.
| Ticker / NAME | Correlation To RXMD | 1D Price Change % | ||
|---|---|---|---|---|
| RXMD | 100% | N/A | ||
| PETS - RXMD | 10% Poorly correlated | +35.78% | ||
| HITI - RXMD | 9% Poorly correlated | +2.26% | ||
| WBA - RXMD | 5% Poorly correlated | +0.43% | ||
| SSY - RXMD | 4% Poorly correlated | -8.35% | ||
| SAEYY - RXMD | 4% Poorly correlated | N/A | ||
More | ||||